from WND:

The medical profession around the globe has been focused over the last few flu seasons on COVID and its after-effects.

That includes those medicine manufacturers, some of whom profited by billions of dollars for their work producing those experimental COVID shots.

But that focus has come with a cost: that some medicines now are hard to find, delayed and worse, unavailable.